Daily Stock Opinions and Ratings

Opinions

Jenny Harrington, CEO, Gilman Hill Asset ManagementOrganonOGNBUYJul 14, 2023

Spun off from Merck two years, but has been sitting in the penalty box. Pays a 5.5% dividend at 5x earnings.

Jenny Harrington, CEO, Gilman Hill Asset Management

Unknown

Unlock Rating

$20.59

Stock price when the opinion was issued

$13.44

As of Jun 12, 2026. Market Open.

Pharma & Healthcare

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

Wealthica Track your Stocks in your Watch List

You might be interested:

DON'T BUY

Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook.

DON'T BUY

It has no growth.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Jenny Harrington, CEO, Gilman Hill Asset ManagementOrganonOGNBUYJul 14, 2023

You might be interested:

Organon(OGN)

Organon(OGN)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals